Background The role of mineralocorticoid receptor antagonists (MRAs) in acute myocardial infarction (MI) remains controversial, with conflicting evidence from landmark trials. We aimed to assess the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback